Dr. Hardesty is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Geffen Hall
885 Tiverton Ave
Los Angeles, CA 90095
Summary
- Dr. Anna Hardesty, based in Los Angeles, CA, is an Infectious Disease specialist. She completed her medical degree at the University of Washington School of Medicine in 2019, followed by a Residency in Internal Medicine and a Chief Residency at Brown University. She is currently undertaking a Fellowship in Infectious Disease at UCLA David Geffen School of Medicine/UCLA Medical Center, due to complete in 2025. Dr. Hardesty's research has been published in numerous esteemed journals, including The Annals of Pharmacotherapy, Systematic Reviews, American Journal of Transplantation, Plos One, and the International Journal of Clinical Practice. Her work focuses largely on COVID-19, specifically in relation to organ transplant recipients and hospitalization outcomes.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Infectious Disease, 2023 - 2025
Brown UniversityChief Residency, Internal Medicine, 2022 - 2023- Brown UniversityResidency, Internal Medicine, 2019 - 2022
University of Washington School of MedicineClass of 2019
Certifications & Licensure
CA State Medical License 2023 - 2025
RI State Medical License 2019 - 2024- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 1 citationsElevated Tacrolimus Levels at Time of Diagnosis of COVID-19 Compared to Baseline Among Hospitalized Organ Transplant Recipients.Krista Mecadon, Anna Hardesty, Kendra Vieira, Ralph Rogers, Basma Merhi
The Annals of Pharmacotherapy. 2022-02-18 - 1 citationsComparison of COVID-19 outcomes in organ transplant recipients (OTr) and non-transplant patients: a study protocol for rapid review.Alexis Hope Lerner, Elizabeth J Klein, Anna Hardesty, Orestis A. Panagiotou, Chelsea Misquith
Systematic Reviews. 2021-11-21 - 32 citationsUse of anti-spike monoclonal antibodies in kidney transplant recipients with COVID-19: Efficacy, ethnic and racial disparities.Elizabeth J Klein, Anna Hardesty, Kendra Vieira, Dimitrios Farmakiotis
American Journal of Transplantation. 2021-09-30
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
